Clinical trials
Type 2 diabetes clinical trials
A condition where the body can’t use insulin properly, raising blood sugar. We’re tracking 1,059 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07433192Recruiting
A study on luseogliflozin for type 2 diabetes
This trial is looking at how well a diabetes medicine called luseogliflozin works and how tolerable it is for people with type 2 diabetes. It includes patients who have already started taking the drug as part of their regular care.
AnapaAges 18 years+ - NCT07431359Recruiting
Mediterranean diet study for type 2 diabetes patients
This trial looks at what people with type 2 diabetes know about diet and how often they eat a Mediterranean diet. It aims to understand if this way of eating can help with diabetes management.
Peschiera del Garda, VeronaAges 18–80 - NCT07428746RecruitingPhase 3
GLP-1 drug for bone health in older women with diabetes
This study tests whether a diabetes medication called a GLP-1 receptor agonist can help improve bone and muscle health in older women with type 2 diabetes who are at risk for osteoporosis. It aims to see if the drug can strengthen bones and prevent falls.
Atlanta, GeorgiaAges 65 years+ - NCT07434791Recruiting
Goal-directed therapy to protect kidneys and heart in diabetic kidney disease
This study tests whether a goal-directed treatment plan using several medications can lower the risk of kidney and heart problems for people with diabetes and kidney disease. It aims to help you manage your condition more effectively.
Toronto, OntarioAges 18 years+ - NCT07433257Recruiting
Steroid injection for carpal tunnel with diabetes
This study tests if a steroid injection in the wrist helps people with carpal tunnel syndrome, comparing results between those with and without type 2 diabetes. If you have mild to moderate carpal tunnel and either well-controlled diabetes or no diabetes, you may be able to join.
Istanbul, IstanbulAges 18–75 - NCT07427134Recruiting
Insulin dose calculator app for type 1 diabetes in children
This study tests a new insulin dose calculator app for children under 12 with type 1 diabetes who use daily insulin shots and already count carbs.
MosulAges 1–12 - NCT07416656Recruiting
Checking blood sugar test accuracy for arthritis patients on sulfasalazine
This study checks if the medicine sulfasalazine affects a blood sugar test (HbA1c) in people with inflammatory arthritis. If you have arthritis, take sulfasalazine, and have higher blood sugar or diabetes, this trial may help understand your glucose levels.
Silkeborg, Central JutlandAges 18 years+ - NCT07420634Recruiting
Understanding medicine-taking habits in adults with chronic conditions
This study looks at why some people take their long-term medicines as prescribed and others don't. By understanding the reasons, researchers hope to find better ways to support patients in managing their health.
Ambāla, HaryanaAges 18–70 - NCT07422831Enrolling by invitation
Intermittent glucose sensor use for type 2 diabetes
This trial is testing whether using a continuous glucose monitor (CGM) for different lengths of time helps people with type 2 diabetes understand their blood sugar patterns. You won't need to change your current diabetes medications.
Aurora, ColoradoAges 18 years+ - NCT06331338Recruiting
Decision cycle for better blood sugar control in type 2 diabetes
This study tests a new way to help people with type 2 diabetes make decisions about their blood sugar control. The goal is to see if this approach can improve your diabetes management.
HsinchuAges 18 years+ - NCT07415954RecruitingPhase 2
Testing a new diabetes medicine for blood sugar control
This study tests a new medicine, NNC0662-0419, in people with type 2 diabetes. You must be willing to lose a lot of weight (more than a quarter of your current weight) as part of the study to see if the medicine helps lower blood sugar.
Lancaster, CaliforniaAges 18–75 - NCT07409714RecruitingEarly Phase 1
Montelukast for kidney and heart health in young adults with type 2 diabetes
This trial tests if montelukast, a common asthma medication, can help protect the kidneys and heart in adolescents and young adults with type 2 diabetes. It looks at how the drug affects markers of kidney function and blood vessel health over time.
Aurora, ColoradoAges 14–24 - NCT07414914Recruiting
Self-massage with exercise for type 2 diabetes
This trial compares adding self-massage to exercise versus exercise alone for people with type 2 diabetes. It aims to see if the massage technique helps improve foot health and function.
Izmir, İzmirAges 30–65 - NCT07415720Recruiting
Artichoke and Mediterranean diet to prevent type 2 diabetes
This study tests whether a special extract from artichoke by-products, combined with a Mediterranean diet, can help prevent type 2 diabetes in people who are at risk. It aims to improve how your body handles sugar and insulin.
Pamplona, NavarreAges 18–75 - NCT06825182RecruitingPhase 3
Islet alpha cell function in new type 2 diabetes
This trial looks at how certain cells in the pancreas work in people newly diagnosed with type 2 diabetes. It may help doctors understand the disease better and find new treatment approaches.
Nanjing, JiangsuAges 18 years+ - NCT06826235Recruiting
Date consumption, hunger and appetite in type 2 diabetes
This study looks at how eating dates might affect hunger and appetite in adults with type 2 diabetes. It aims to see if dates can help manage food cravings (hedonic hunger).
Erzurum, PalandökenAges 19–50 - NCT07398495Recruiting
Exercise program for diabetes and muscle loss
This study tests whether a special exercise program can help middle-aged and older adults who have both type 2 diabetes and muscle loss. It aims to improve muscle strength, balance, and overall health.
Taichung, TaiwanAges 45–85 - NCT07394114RecruitingPhase 3
Study of a new medicine for type 2 diabetes not controlled by diet and exercise
This trial tests a new medicine called HDM1005 for people with type 2 diabetes who haven't been helped enough by diet and exercise alone, and who haven't taken any diabetes medication in the last 12 weeks. It aims to see if the medicine can help lower blood sugar levels safely.
BeijingAges 18–75 - NCT07390422Recruiting
PulsENDO for diabetes and fatty liver
This trial tests a new endoscopic procedure (pulsENDO) for people with type 2 diabetes and fatty liver disease whose blood sugar remains high despite taking diabetes pills. It aims to see if this treatment can improve blood sugar control and liver health.
ShatinAges 18–70 - NCT07389772Enrolling by invitation
Immune markers in tooth retreatments for diabetics
This study tests whether different ways of activating the immune system during root canal retreatment affect levels of certain immune markers (TLR9, IL6, IL10, TNF-alfa) in people with type 2 diabetes. If you need a repeat root canal on a front tooth or lower premolar, you may be able to join.
Kirikkale, KırıkkaleAges 18–50 - NCT07394075Enrolling by invitation
CGM support for type 2 diabetes management
This trial tests whether using continuous glucose monitor (CGM) data can help doctors and patients better manage type 2 diabetes. It is for people who already use insulin and a CGM device to check their blood sugar levels.
Minneapolis, MinnesotaAges 18–75 - NCT07386340Recruiting
Testing a new continuous glucose monitor with flash readings
This study tests a new sensor system that tracks glucose levels continuously and can give a quick reading when you wave a device over it. It aims to see if it's safe and accurate for people with diabetes.
Escondido, CaliforniaAges 18 years+ - NCT07387393Enrolling by invitation
PILI Pasifika Lifestyle Program for Native Hawaiian and Pacific Islander adults
This study tests a 3-month lifestyle program called PILI Pasifika, which includes healthy eating, physical activity, and support for social needs like housing or food. It aims to help Native Hawaiian and Pacific Islander adults with conditions like diabetes or high blood pressure improve their health in real-world settings.
Fayetteville, ArkansasAges 18 years+ - NCT03059069RecruitingPhase 4
Gliatamin for low mood in adults with type 2 diabetes
This trial tests whether gliatamin (choline alphoscerate) can improve depressive mood in people with type 2 diabetes. You may be eligible if your diabetes is fairly controlled and your depression symptoms are in a mild-to-moderate range.
SeoulAges 50 years+
Hear when a new Type 2 diabetes trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for type 2 diabetes?
- Yes. Clin2 currently lists 1,059 recruiting type 2 diabetes studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a type 2 diabetes trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a type 2 diabetes trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.